ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)


Volume 18, 15 Issues, 2017


Download PDF Flyer




Current Pharmaceutical Biotechnology

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Davide Prosperi


Department of Biotechnology and Bioscience
University of Milano-Bicocca
Milano
Italy


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.459
5 - Year: 2.33
Browse Contents
Select Volume:


Select Issue:


Select Article:


Abstracted/Indexed in




Endorsement(s)

"Current Pharmaceutical Biotechnology presents the latest developments in the area of biotechnology. This is strongly recommended."

Robert Huber
Nobel Laureate

Forthcoming Special Issue(s)

ANALYTICAL ADVANCES IN CLINICAL AND FORENSIC TOXICOLOGY


Guest Editor(s): Marzena Laskowska
Tentative Publication Date: March, 2018
Submit Abstract via Email Download Description
Published Special Issue(s)

DIAGNOSTIC AND PROGNOSTIC INSIGHTS OF BIOMARKERS IN CARDIOVASCULAR DISEASES


Current Pharmaceutical Biotechnology, Volume 18, Number 06
Guest Editor(s): Michael Behnes, Ibrahim Akin

Authors' Comments
It was a great experience for me working with Bentham Science Publishers because of the following reasons:
-High quality services
-Professionalism
-Cordiality
-Great and kind cooperation and collaboration

Dr. Helmy Selman
(The CIVF Center Doha Center Clinic Hospital Doha, Qatar)



Current Pharmaceutical Biotechnology

,

Volume 18

-

Number 7



Review Article

Adulteration Practices of Psychoactive Illicit Drugs: An Updated Review

, 18(7): 524 - 530

Renata Solimini, Maria C. Rotolo, Manuela Pellegrini, Adele Minutillo, Roberta Pacifici, Francesco P. Busardò and Simona Zaami


DOI: 10.2174/1389201018666170710184531


Abstract PubMed Reprints Eprints Permissions




Research Article

Research Article

Serum Free or Not: Two Distinct Recycling Mechanisms Mediated by Alpha v Beta 3 Integrin


Yanan Cui, Suxin Li, Binlong Chen, Bing He, Lan Yuan, Wenbing Dai, Hua Zhang, Xueqing Wang and Qiang Zhang


View Abstract View on PubMed



Clinical Applications of Intravenous Immunoglobulins in Child Neurology


Maria Gogou, Efimia Papadopoulou-Alataki, Martha Spilioti, Sofia Alataki and Athanasios Evangeliou


View Abstract View on PubMed



PeMtb: A Database of MHC Antigenic Peptide of Mycobacterium tuberculosis


Qamar Zia, Asim Azhar, Shadab Ahmad, Mohammad Afsar, Ziaul Hasan, Mohammad Owais, Mahfooz Alam, Shabab Akbar, Magdah Ganash, Ghulam Md Ashraf , Swaleha Zubair and Gjumrakch Aliev


View Abstract View on PubMed



Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate


Lillian Li, Marina Kirkitadze, Kamaljit Bhandal, Cristopher Roque, Eric Yang, Bruce Carpick and Nausheen Rahman


View Abstract View on PubMed



Gonadotropin Releasing Hormone Agonists or Antagonists for Preimplantation Genetic Diagnosis (PGD)? A Prospective Randomised Trial


W Verpoest, A De Vos , M De Rycke, S Parikh , C Staessen , H Tournaye , M De Vos, V Vloeberghs and C Blockeel


View Abstract View on PubMed



The Impact of Elevated Progesterone on the Initiation of an Artificially Prepared Frozen Embryo Transfer Cycle: A Case Series


Panagiotis Drakopoulos, Corina Mat, Nikolaos P. Polyzos, Samuel Santos-Ribeiro , Arne van de Vijver, Liesbet Van Landuyt, Herman Tournaye and Christophe Blockeel


View Abstract View on PubMed



Drs. Eric Betzig, Stefan W. Hell and William E. Moerner share the 2014 chemistry Nobel for the development of super-resolved fluorescence microscopy.

“The Royal Swedish Academy of Sciences has decided to award the 2014 Nobel Prize in Chemistry to Dr. Eric Betzig at Howard Hughes Medical Institute, Ashburn, U.S.A.; Professor Stefan Hell at Max Planck Institute for Biophysical Chemistry, Göttingen, and the German Cancer Research Center, Heidelberg, Germany; and Professor William Moerner at Stanford University, Stanford, U.S.A., for the development of super-resolved fluorescence microscopy.”

Much research effort was needed to realize that single-cell and single-molecule based approaches directly affect improvements in human health. However, many of these laboratory technologies are not available in a cheap and easy version. Single-molecule based fluorescence imaging and detection have the advantages of a small volume platform, digital analysis, elimination of processing steps, real-time measurements and automation of sample preparation. In 2015, Current Pharmaceutical Biotechnology will continue in this direction with quality papers that can be expected to trigger further investigations.

Drs. Eric Betzig and William E. Moerner also developed methods and biotechniques which have enabled the study of single molecules in ongoing chemical reactions in living cells. Because now it is possible to see individual macromolecules moving about in a living cell, we can study chemistry at a single-molecule level and in real life. And this is very important to chemistry because chemistry has traditionally been about studying a large number of molecules and the effect that they have. The journal Current Pharmaceutical Biotechnology has published on this research and has been at the forefront for over more than one decade. Curr. Pharm. Biotechnol. has published thematic issues, original research and review articles about the entirely new possibilities for chemistry and for biochemistry by eminent scientists from around the world, some examples:

Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice

, 2017; 18(3): 204 - 209

Erika Cecchin, Rossana Roncato, Hendrik J. Guchelaar, Giuseppe Toffoli and for the Ubiquitous Pharmacogenomics Consortium


DOI: 10.2174/1389201018666170103103619
Abstract PubMed Reprints Eprints Permissions



Bone microRNAs and Ageing

, 2017; 18(3): 210 - 220

Tilen Kranjc, Barbara Ostanek and Janja Marc


DOI: 10.2174/1389201018666170203091828
Abstract PubMed Reprints Eprints Permissions



Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital

, 2017; 18(3): 274 - 281

Raffaele La Russa, Vittorio Finesch, Mariantonia Di Sanzo, Vittorio Gatto, Alessandro Santurro, Gabriella Martini, Matteo Scopetti and Paola Frati


DOI: 10.2174/1389201018666170207124835
Abstract PubMed Reprints Eprints Permissions



Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics

, 2017; 18(3): 253 - 262

Stefania Schiavone, Margherita Neri, Cristoforo Pomara, Irene Riezzo, Luigia Trabace and Emanuela Turillazzi


DOI: 10.2174/1389201018666170207130236
Abstract PubMed Reprints Eprints Permissions



Personalized Medicine Applied to Forensic Sciences: New Advances and Perspectives for a Tailored Forensic Approach

, 2017; 18(3): 263 - 273

Alessandro Santurro, Anna Maria Vullo, Marina Borro, Giovanna Gentile, Raffaele La Russa, Maurizio Simmaco, Paola Frati and Vittorio Fineschi


DOI: 10.2174/1389201018666170207141525
Abstract PubMed Reprints Eprints Permissions



Personalised Healthcare: The DiMA Clinical Model

, 2017; 18(3): 242 - 252

Marina Borro, Giovanna Gentile, Luigi Cipolloni, Zeno Foldes-Papp, Paola Frati, Alessandro Santurro, Luana Lionetto and Maurizio Simmaco


DOI: 10.2174/1389201018666170208125131
Abstract PubMed Reprints Eprints Permissions



Clinical Applications of Personalized Medicine: A New Paradigm and Challenge

, 2017; 18(3): 194 - 203

Mariantonia Di Sanzo, Luigi Cipolloni, Marina Borro, Raffaele La Russa, Alessandro Santurro, Matteo Scopetti, Maurizio Simmaco and Paola Frati


DOI: 10.2174/1389201018666170224105600
Abstract PubMed Reprints Eprints Permissions



Advertisement

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science